secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001104659-24-112750
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA Sciences prices $6.5M registered direct and private placement
-------------------------------------------------------------------------

- Gross proceeds ~$6.5M from sale of 20.3M shares (or pre-funded warrants) at $0.32 per share.
- Issues Series C and D warrants to purchase 20.3M shares each, both exercisable at $0.32 after stockholder approval.
- Series D exercise price resets to lower of $0.32 or lowest VWAP around a future reverse split, floor $0.0634.
- Amends existing Series A warrants to set floor price at $0.20 for price protection provisions.
- Net proceeds for therapeutic DNA production services development and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465924112750/0001104659-24-112750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465924112750/tm2427064d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-112750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer